HCAT - NASDAQ

Health Catalyst, Inc.

HCAT·NASDAQ

$1.33

+1.9%

HealthcareMedical - Healthcare Information Services

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$98.28M

EPS-2.5500

P/E Ratio-0.52

Earnings Date08/06/2026

502.64M

Assets

-41%

3Y-33.0%

5Y-13.0%

10Y+356.0%

256.86M

Total Liabilities

-48%

3Y-22.0%

5Y-15.0%

10Y-31.0%

245.78M

Total Equity

-33%

3Y-42.0%

5Y-11.0%

10Y-195.0%

Health Catalyst, Inc. Funding & Solvency Profile

HCAT · NASDAQ

Current Assets

Cash & Cash Equivalents50.81M

Net Receivables59.13M

Inventory0.00

Other Current Assets14.45M

Total Current Assets169 M

Non-Current Assets

Property, Plant & Equipment40.48M

Goodwill & Intangible Assets286.75M

Long-Term Investments0.00

Other Non-Current Assets6.11M

Total Non-Current Assets47 M

Total Assets

502.64M

Financial Health Analysis

Current Ratio

1.89x

Strong liquidity. The company has adequate resources to meet short-term liabilities.

Debt-to-Equity Ratio

1.05x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

80 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

34% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Health Catalyst, Inc. Balance Sheet

HCAT • NASDAQ

Health Catalyst, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	50.8M	249.6M	106.3M	116.3M	193.2M	92M	18M	28.4M	23M
Short-Term Investments	44.9M	142.4M	211.5M	247.2M	251.8M	178.9M	210.2M	4.8M	28.5M
Cash & Short-Term Investments	95.7M	392M	317.7M	363.5M	445M	270.9M	228.3M	33.2M	51.5M
Net Receivables	59.1M	57.2M	60.3M	48M	48.8M	48.3M	27.6M	27.7M	17.1M
Accounts Receivables	59.1M	57.2M	60.3M	48M	48.8M	48.3M	27.6M	27.7M	17.1M
Prepaids	0.0	0.0	0.0	0.0	0.0	10.6M	8.4M	5.3M	2.1M
Other Current Assets	14.4M	16.5M	15.4M	16.3M	14.6M	0.0	0.0	649K	762K
Total Current Assets	169.3M	465.7M	393.4M	427.8M	508.4M	329.8M	264.2M	66.9M	71.4M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	40.5M	41.5M	39.6M	42.6M	44.4M	37.6M	8.1M	11M	5.4M
Goodwill	209.1M	259.8M	190.7M	186M	170M	107.8M	3.7M	3.7M	3.7M
Intangible Assets	77.7M	86.1M	73.4M	92.2M	104.8M	98.9M	25.5M	28.3M	29.6M
Goodwill & Intangible Assets	286.8M	345.8M	264M	278.2M	274.8M	206.7M	29.2M	32M	33.3M
Other Non-Current Assets	6.1M	6M	4.7M	3.7M	4.5M	3.6M	810K	1.1M	243K
Total Non-Current Assets	333.3M	393.3M	308.4M	324.5M	323.7M	247.9M	38.1M	44.1M	38.9M
Total Assets	502.6M	858.9M	701.8M	752.3M	832.1M	577.7M	302.4M	111M	110.3M
LIABILITIES
CURRENT LIABILITIES
Total Payables	9.4M	11.4M	6.6M	4.4M	4.7M	7.3M	3.6M	1.8M	833K
Accounts Payable	9.4M	11.4M	6.6M	4.4M	4.7M	5.3M	3.6M	1.8M	833K
Other Payables	0.0	0.0	0.0	0.0	0.0	2M	0.0	0.0	0.0
Accrued Expenses	0.0	14.7M	11.6M	12.2M	17.4M	6.7M	4.3M	5.9M	811K
Short Term Debt	5.4M	231.2M	0.0	0.0	0.0	0.0	2.8M	1.3M	0.0
Capital Lease Obligations (Current)	0.0	3.6M	3.4M	3.4M	3.4M	2.6M	2.8M	2.6M	2.1M
Deferred Revenue	56.1M	53.3M	55.8M	55M	56.6M	47.1M	30.7M	24.8M	10.7M
Other Current Liabilities	18.7M	11.7M	11.7M	7.5M	10.9M	24.3M	4.1M	5.5M	16.3M
Total Current Liabilities	89.6M	325.9M	89M	82.5M	93.1M	88M	48.2M	41.8M	30.8M
NON-CURRENT LIABILITIES
Long Term Debt	151.6M	151.2M	228M	226.5M	180.9M	169M	48.2M	18.8M	9.6M
Deferred Revenue (Non-Current)	410K	249K	77K	105K	929K	1.9M	1.5M	7.3M	0.0
Deferred Tax Liabilities (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	1.9M	-4.2M	0.0
Other Non-Current Liabilities	798K	154K	74K	121K	14.8M	19.1M	0.0	413.6M	328.5M
Total Non-Current Liabilities	167.3M	167.9M	245.9M	244.8M	216.9M	213.6M	53.5M	443.9M	339M
Capital Lease Obligations	14.2M	19.9M	21M	21.5M	23.7M	26.3M	4.5M	6.8M	3M
Total Liabilities	256.9M	493.7M	334.9M	327.3M	310M	301.6M	101.7M	485.7M	369.7M
SHAREHOLDERS' EQUITY
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	302.4M	409.8M	321.6M
Common Stock	1.6B	1.6B	1.5B	1.4B	53K	43K	37K	5K	5K
Additional Paid-In Capital	0.0	0.0	0.0	0.0	1.4B	1B	811M	0.0	0.0
Retained Earnings	-1.4B	-1.2B	-1.1B	-999M	-878.9M	-725.7M	-610.5M	-374.8M	-259.5M
Accumulated Other Comprehensive Income/Loss	1.6M	-835K	33K	-648K	-67K	61K	72K	-1K	-12K
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-409.8M	-321.6M
Total Stockholders' Equity	245.8M	365.2M	366.9M	425M	522.1M	276.1M	200.6M	-374.8M	-259.5M
Total Equity	245.8M	365.2M	366.9M	425M	522.1M	276.1M	200.6M	-374.8M	-259.5M
SUMMARY
Total Liabilities & Equity	502.6M	858.9M	701.8M	752.3M	832.1M	577.7M	302.4M	111M	110.3M
Total Investments	44.9M	142.4M	211.5M	247.2M	251.8M	178.9M	210.2M	4.8M	28.5M
Total Debt	171.2M	402.3M	249.1M	248M	204.6M	195.3M	52.7M	26.9M	12.6M
Net Debt	120.4M	152.6M	142.8M	131.7M	11.4M	103.3M	34.6M	-1.5M	-10.4M
Shares Outstanding	70,373,625	70,373,625	70,373,625	70,373,625	70,373,625	70,373,625	70,373,625	70,373,625	70,373,625

SEC Filings

HCAT - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
10-Q 10-Q 2026 Q1 Q1	May 11, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 11, 2026	May 11, 2026	2026	View Filing
10-K/A 10-K/A 2025 FY (Amended) FY	April 30, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	April 30, 2026	April 29, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 27, 2026	April 24, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 03, 2026	March 31, 2026	2026	View Filing
10-K 10-K 2025 FY FY	March 12, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	March 12, 2026	March 12, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 18, 2026	February 12, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 23, 2026	January 20, 2026	2026	View Filing

Showing 1 to 10 of 108 filings

Related Guides

Blog Categories

Continue your HCAT research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.